 LAVAL, QC , ROCKVILLE, MD and CAMBRIDGE, United Kingdom , Nov. 27, 2019 CNW Telbec - Liminal BioSciences Inc. NASDAQ: LMNL TSX: LMNL Liminal BioSciences or the Company, a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat unmet needs in patients with liver, respiratory and kidney disease, announced today, today announced that members of the management team will provide a business overview and update at the Piper Jaffray 31st Annual Healthcare Conference at 08:10 ET on Wednesday, December 4, 2019 in New York, USA . The presentation will be webcast live on the Webcasts page of the Investors Media section of Liminal BioSciences website, or by following the links below in your web browser. An archived replay of the webcast will be available on Liminal BioSciences website for at least 7 days after the live event concludes. 